A collaborative group of Missouri and Kansas researchers have gotten a $412,000 federal grant to explore the effectiveness of the dietary supplement Devil’s Claw for treating early-stage joint osteoarthritis.
Researchers from the University of Missouri-Kansas City are working with researchers from the University of Missouri in Columbia and the International Clinical Research Institute in Overland Park on the two-year grant study. And if the results are positive, additional support will be provided for further studies.
Osteoarthritis is sometimes called degenerative joint disease or degenerative arthritis and is the most common chronic condition of the joints, affecting approximately 27 million Americans. Read more.